Adial Pharmaceuticals, Inc. Other Nonoperating Expense
Adial Pharmaceuticals, Inc. (ADIL) reported Other Nonoperating Expense of $43 for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2024-08-13
- Adial Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2023-09-30 was $0.00.
- Adial Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2023-06-30 was $51.90K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month |
|---|---|---|---|
| 2024-06-30 | $43.00 10-Q · filed 2024-08-13 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $51.90K derived: sum of 2 quarters · filed 2024-08-13 | $51.90K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $51.90K 10-Q · filed 2024-08-13 | $51.90K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |